Use of Smart Drugs in Cancer Treatment

Smart drugs are biotechnological medications designed to directly target cancer cells while sparing healthy cells, representing a breakthrough in cancer treatment revolution. These drugs aim to neutralize cancer cells by analyzing their characteristics at the cellular and molecular levels. Unlike conventional chemotherapy, they exhibit fewer side effects and enable personalized treatment opportunity.

The first targeted cancer therapies were developed in the early 2000s. Advances in molecular biology and genetics enabled the production of smart drugs that act based on specific features of cancer cells. Today, these drugs have become one of the standard treatment options for many types of cancer.

Smart drugs target specific proteins or genetic mutations that drive the growth and proliferation of cancer cells. The main mechanisms used include:

Tyrosine Kinase Inhibitors (TKIs): Block signaling pathways that promote cancer cell growth signal.

Monoclonal Antibodies: Bind to specific proteins on the surface of cancer cells, enabling the immune system to recognize and attack them none.

Immune Checkpoint Inhibitors: Block mechanisms that suppress the immune system, thereby facilitating the destruction of cancer cells by the body’s own defenses.

Smart drugs are used in the treatment of many cancer types, including primarily lung, breast, colon, skin (melanoma), and blood (leukemia, lymphoma) cancers. These drugs are selected based on the genetic profile of the tumor, offering a personalized treatment approach.

In recent years, Türkiye has made significant progress in developing the active ingredients of smart drugs using local capabilities domestic. Domestic biotechnology companies and universities are conducting research to produce molecules used in cancer therapy. The goal is to provide cancer patients with more accessible and affordable treatment options.

^{Smart Drug-}AA

• Targets cancer cells without damaging healthy cells.
• Has fewer side effects compared to conventional chemotherapy.
• Enables personalized treatment.
• Promotes more effective and longer-lasting responses.

• High cost.
• Limited effectiveness against certain cancer types.
• Risk of developing drug resistance.

Smart drugs in cancer treatment represent the cutting edge of personalized medicine and biotechnology. The development of next-generation drugs and the expansion of local production capabilities production are regarded as a critical milestone in advancing cancer therapy dunum.